Previously, we reported that higher NR2E3 levels are strongly associated with good clinical outcomes in breast cancer by maintaining the expression of estrogen receptor α (ESR1), a major guideline for breast cancer prognosis and treatment6. The gene discussed is ESR1; the disease is breast carcinoma.